We are live on ! Find out more
VCIM

Velan Capital Investment Management Portfolio holdings

AUM $160M
1-Year Est. Return 517.12%
This Fund
S&P 500
This Quarter Est. Return
+52.62%
1 Year Est. Return
+517.12%
3 Year Est. Return
+2,524.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$117M
AUM Growth
+$4.12M
Cap. Flow
+$13.5M
Cap. Flow %
11.54%
Top 10 Hldgs %
77.49%
Holding
42
New
14
Increased
5
Reduced
2
Closed
11

Top Buys

Rank Stock Value
1
JSPR icon
Jasper Therapeutics
JSPR
+$14.8M
2
PRAX icon
Praxis Precision Medicines
PRAX
+$14.6M
3
HRTX icon
Heron Therapeutics
HRTX
+$5.01M
4
CABA icon
Cabaletta Bio
CABA
+$2.34M
5
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
+$2.06M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$7.83M
2
INSP icon
Inspire Medical Systems
INSP
+$2.52M
3
IMTX icon
Immatics
IMTX
+$2.18M
4
HCSG icon
Healthcare Services Group
HCSG
+$1.53M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$1.29M

Sector Composition

Rank Sector Weight
1 Healthcare 96.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COLL icon
26
Collegium Pharmaceutical
COLL
$834M
$530K 0.45%
22,095
-22,353
-50% -$593K
MLTX icon
27
MoonLake Immunotherapeutics
MLTX
$1.47B
$501K 0.43%
+23,400
New +$393K
ANNX icon
28
Annexon
ANNX
$873M
$385K 0.33%
+100,000
New +$550K
IRON icon
29
Disc Medicine
IRON
$3.09B
$260K 0.22%
+12,269
New +$273K
AVDL
30
DELISTED
Avadel Pharmaceuticals
AVDL
$236K 0.2%
+25,743
New +$212K
BOLT icon
31
Bolt Biotherapeutics
BOLT
$6.63M
$195K 0.17%
+7,000
New +$205K
CHRS icon
32
Coherus Oncology
CHRS
$181M
– –
-82,605
Closed -$654K
HCSG icon
33
Healthcare Services Group
HCSG
$1.43B
– –
-127,252
Closed -$1.53M
IMTX icon
34
Immatics
IMTX
$1.33B
– –
-250,000
Closed -$2.18M
INSP icon
35
Inspire Medical Systems
INSP
$1.68B
– –
-10,000
Closed -$2.52M
SPY icon
36
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
– –
-50,000
Closed -$19.1M
XENE icon
37
Xenon Pharmaceuticals
XENE
$6.31B
– –
-20,000
Closed -$789K
LMDX
38
DELISTED
LumiraDx Limited Common Shares
LMDX
– –
-571,428
Closed -$514K
SGEN
39
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-10,000
Closed -$1.29M
BLU
40
DELISTED
BELLUS Health Inc.
BLU
– –
-100,000
Closed -$822K
CFMS
41
DELISTED
Conformis, Inc. Common Stock
CFMS
– –
-206,256
Closed -$685K
HZNP
42
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-68,829
Closed -$7.83M
1
2

Similar funds

BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
LCA
Legend Capital Advisors New York $160M AUM
SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
RP
RIHO Partners Tucson, Arizona $159M AUM
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return
RCWM
Royal Capital Wealth Management Carmel, Indiana $161M AUM 18.42% 1-Year Est. Return

Velan Capital Investment Management's Q1 2023 Portfolio in Review

As of Q1 2023, Velan Capital Investment Management held 42 positions worth $117M, up 3.6% from $113M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Velan Capital Investment Management deployed $13.5M of net new capital in Q1 2023, opening 14 new positions and adding to 5 existing holdings. Its largest new stake was Praxis Precision Medicines: 345,667 shares worth $4.19M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 83% a quarter earlier.

On the sell side, the largest reduction was Collegium Pharmaceutical, an estimated $593K trimmed.

  • Velan Capital Investment Management's largest Q1 2023 buy was Praxis Precision Medicines: 345,667 shares worth $4.19M.
  • Velan Capital Investment Management added most to Jasper Therapeutics in Q1 2023, an estimated $14.8M increase.
  • Velan Capital Investment Management's biggest Q1 2023 reduction was Collegium Pharmaceutical, cutting an estimated $593K.
  • Velan Capital Investment Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, selling an estimated $7.83M.
  • Velan Capital Investment Management's ten largest holdings make up 77% of its $117M portfolio in Q1 2023.
  • Velan Capital Investment Management opened 14 new positions and closed 11 in Q1 2023.
  • Velan Capital Investment Management's portfolio value rose 3.6% quarter-over-quarter to $117M.

Based on Velan Capital Investment Management's 13F filing for Q1 2023, filed 15 May 2023.